-
Evaluation of the Antihistamines LINS01 as Ligands of the Dopamine D2/D3 Receptors
Vol. 1, 2019 -108856 -
Docking Analysis of LINS01 Compounds Binding at Histamine H3 and H4 Receptors Led to Novel Improved Compounds
Vol. 1, 2019 -108997 -
Effect of the Meta Substitution on LINS03 Analogues - Antitrypanosoma Activity and Selectivity
Vol. 1, 2019 -108866 -
Screening of LINS05 compounds as acetylcholinesterase inhibitors
Vol. 1, 2019 -108920 -
LINS01 Compounds as Vasodilating Agents: Investigation of Potency on an Aortic Ring Ex Vivo Model
Vol. 1, 2019 -108963
Publications in other proceedings
-
BrazMedChem 2022
o-Coumarates and cyclized analogues as promising inhibitors of tyrosinase
-
BrazMedChem 2022
Heterocyclic multitargeting ligands of cholinesterases, histamine and dopamine receptor subtypes: promising agents for cognitive dysfunctions
-
BrazMedChem 2022
Fragment-based design of anticholinesterase and chelating agents in a multi-target approach
-
BrazMedChem 2022
Improving Antitrypanosomal Activity, Selectivity and Drug-Likeness of LINS03 Amide Series by Modulation of Physicochemical Properties
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
